Looks promising and yet the market totally discounts the news.
Ann: First phase 1B trial of NK cells with IL-2 & Vactosertib, page-2
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.776M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.0¢ | 0.9¢ | $9.73K | 1.077M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 5624045 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 3249484 | 8 |
View Market Depth
| Last trade - 14.35pm 01/11/2024 (20 minute delay) ? |
| CHM (ASX) Chart |